Gregory Milman, Ph. D. Director, Office for Innovation and Special Programs Division of Extramural Activities National Institute of Allergy and Infectious Diseases, NIH, DHHS
Adobe Flash Player not installed or older than 9.0.115!
_______________________
COST:Free, but registration required. HOW TO PARTICIPATE?: This series is online. You need a computer with web access for the visual/audio. Q&A is conducted by a chat box to the speakers.
WHO SHOULD PARTICIPATE IN THE WEBINAR?:
Whether you're in industry or academia, the new NIH SHIFT Small Business Innovation Research (SBIR) Program offers a win-win opportunity. Companies get research dollars, expertise, and potentially, collaborators and resources. Academic investigators get to move to a company where as Principal Investigators (PI) on an SBIR grant, they use their research skills to develop innovative new products. Funding limits are higher and awards are longer than for normal SBIR grants. Nine NIH institutes and two centers participate in the SHIFT Program: NIA, NIAAA, NIAMS, NIAID, NICHD, NIDDK, NIDA, NIGMS, NHLBI, NCCAM, and NCRR. Learn more at Looking to SHIFT Your Career to Business.
The SHIFT Connector is a pilot Web site to help investigators and businesses connect and apply to the SHIFT SBIR program. The SHIFT Connector hosts:
Gregory Milman, Ph. D. (Director, Office for Innovation and Special Programs, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, NIH, DHHS)
Gregory Milman, Ph.D., is Director of the Office for Innovation and Special Programs in the National Institute of Allergy andInfectious Diseases (NIAID). He manages the $100 million NIAID small business programs and is acclaimed for his advice on NIH grant preparation and research funding.
Dr. Milman was Assistant Professor of Biochemistry at the University of California, Berkeley from 1970-1976, Associate Professor of Biochemistry and Immunology at Johns Hopkins University from 1976-1988, and visiting Professor in Honors at the University of Maryland College Park from 1997-2000. In 1985, he obtained NIH SBIR funding to start a biotechnology company focusing on viral diagnostics. From 1988-1999, Dr. Milman managed the NIAID $70 million basic AIDS research program. He established the NIH Centers for AIDS Research (CFARs) and the NIH AIDS Reagent Program. From 1997 to 2000, Dr. Milman organized the NIH Bioengineering Consortium (BECON) and acted as its first Executive Secretary. In 2000, Dr. Milman was on the NIH staff in President Clinton's White House Office of Science Policy.
Dr. Milman has served on the Board of Directors of the Biotechnology Industry Organization Council of Biotechnology Centers, the Maryland Governor's Commission on the Development of Advanced Technology Business, and the Advisory Board for the National Institute of Science and Technology (NIST) Advanced Technology Program (ATP).
